Datasets:
case_id string | case_submitter_id string | project_id string | gdc_portal_url string | primary_site string | disease_type string | index_date string | consent_type string | days_to_consent int64 | days_to_lost_to_followup int64 | lost_to_followup string | demographic dict | diagnoses list | follow_ups list | exposures list | family_histories list | samples list | samples_masked_somatic_mutation list | samples_gene_expression_quantification list | survival_derived dict | clinical_supplement dict |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7e61e3b8-c617-4a5f-afdf-689521c9a670 | TCGA-OR-A5LF | TCGA-ACC | https://portal.gdc.cancer.gov/cases/7e61e3b8-c617-4a5f-afdf-689521c9a670 | Adrenal gland | Adenomas and Adenocarcinomas | Diagnosis | Consent Waiver | null | null | null | {
"demographic_id": "e469eec9-401b-5562-add8-b38588888ed2",
"submitter_id": "TCGA-OR-A5LF_demographic",
"age_at_index": 74,
"age_is_obfuscated": false,
"cause_of_death": null,
"cause_of_death_source": null,
"country_of_birth": null,
"country_of_residence_at_enrollment": "Germany",
"days_to_birth": -27... | [
{
"diagnosis_id": "a9e0828b-c0db-581d-8897-3a0b36c58339",
"submitter_id": "TCGA-OR-A5LF_diagnosis",
"adrenal_hormone": null,
"age_at_diagnosis": 27179,
"ajcc_clinical_m": null,
"ajcc_clinical_n": null,
"ajcc_clinical_stage": null,
"ajcc_clinical_t": null,
"ajcc_pathologic_m": nul... | [
{
"follow_up_id": "7cdc39f7-c76b-4a88-bb2d-df861d3e10a2",
"submitter_id": "TCGA-OR-A5LF_follow_up2",
"adverse_event": null,
"adverse_event_grade": null,
"barretts_esophagus_goblet_cells_present": null,
"cause_of_response": null,
"days_to_adverse_event": null,
"days_to_first_event": n... | [] | [] | [
{
"sample_id": "0b547426-8d18-42db-9832-91d5cba7c370",
"submitter_id": "TCGA-OR-A5LF-01A",
"biospecimen_anatomic_site": null,
"biospecimen_laterality": null,
"catalog_reference": null,
"current_weight": null,
"days_to_collection": 3880,
"days_to_sample_procurement": null,
"diagno... | [
{
"tumor_sample_id": "0b547426-8d18-42db-9832-91d5cba7c370",
"matched_normal_sample_id": "6f8fad82-5a17-4be4-8215-f8f86a8350f6",
"source_file_id": "3f53a3d5-249b-429d-998e-f390d4a6de50",
"Hugo_Symbol": "ZCCHC17",
"Entrez_Gene_Id": 51538,
"Center": "BCM",
"NCBI_Build": "GRCh38",
"Chro... | [] | {
"os_event": 1,
"os_time": 445,
"dss_event": 0,
"dss_time": 445,
"pfi_event": 0,
"pfi_time": 445,
"dfi_event": 0,
"dfi_time": 445
} | {
"patient": {
"bcr_patient_uuid": "7E61E3B8-C617-4A5F-AFDF-689521C9A670",
"bcr_patient_barcode": "TCGA-OR-A5LF",
"form_completion_date": "2014-6-27",
"prospective_collection": "NO",
"retrospective_collection": "YES",
"gender": "FEMALE",
"race": "WHITE",
"ethnicity": "NOT HISPANIC OR L... |
09454ed6-64bc-4a35-af44-7c4344623d45 | TCGA-OR-A5KB | TCGA-ACC | https://portal.gdc.cancer.gov/cases/09454ed6-64bc-4a35-af44-7c4344623d45 | Adrenal gland | Adenomas and Adenocarcinomas | Diagnosis | Informed Consent | 116 | null | No | {"demographic_id":"0e0589ec-863f-5435-8e06-11f27c15727f","submitter_id":"TCGA-OR-A5KB_demographic","(...TRUNCATED) | [{"diagnosis_id":"5df429a5-1ca8-5d31-b94f-ff09ca73e998","submitter_id":"TCGA-OR-A5KB_diagnosis","adr(...TRUNCATED) | [{"follow_up_id":"678761bd-eda9-4534-91d2-19339a67a1db","submitter_id":"TCGA-OR-A5KB_follow_up5","ad(...TRUNCATED) | [] | [] | [{"sample_id":"c82fb2b6-aced-4b03-b8ec-af356496c071","submitter_id":"TCGA-OR-A5KB-11A","biospecimen_(...TRUNCATED) | [{"tumor_sample_id":"fc29b5b8-0e57-4fa7-b9fe-69c5a0b1d83f","matched_normal_sample_id":"c82fb2b6-aced(...TRUNCATED) | [] | {"os_event":0,"os_time":741.0,"dss_event":0,"dss_time":741.0,"pfi_event":1,"pfi_time":214.0,"dfi_eve(...TRUNCATED) | {"patient":{"bcr_patient_uuid":"09454ED6-64BC-4A35-AF44-7C4344623D45","bcr_patient_barcode":"TCGA-OR(...TRUNCATED) |
4f845fea-e823-47d6-89fb-36ee478a43b8 | TCGA-OR-A5JH | TCGA-ACC | https://portal.gdc.cancer.gov/cases/4f845fea-e823-47d6-89fb-36ee478a43b8 | Adrenal gland | Adenomas and Adenocarcinomas | Diagnosis | Informed Consent | 0 | null | No | {"demographic_id":"57fcf92a-9bc7-5bb9-8f27-6d8d22bd34cf","submitter_id":"TCGA-OR-A5JH_demographic","(...TRUNCATED) | [{"diagnosis_id":"805fa903-e4da-52bc-a342-75f5467e0caf","submitter_id":"TCGA-OR-A5JH_diagnosis","adr(...TRUNCATED) | [{"follow_up_id":"2d1e3692-6247-4d36-b12f-f3107957ee1c","submitter_id":"TCGA-OR-A5JH_follow_up4","ad(...TRUNCATED) | [] | [] | [{"sample_id":"5dfdd66b-e079-4b5a-959e-a5558836d2f7","submitter_id":"TCGA-OR-A5JH-01A","biospecimen_(...TRUNCATED) | [{"tumor_sample_id":"5dfdd66b-e079-4b5a-959e-a5558836d2f7","matched_normal_sample_id":"87b9fe70-7847(...TRUNCATED) | [] | {"os_event":0,"os_time":2110.0,"dss_event":0,"dss_time":2110.0,"pfi_event":0,"pfi_time":2110.0,"dfi_(...TRUNCATED) | {"patient":{"bcr_patient_uuid":"4F845FEA-E823-47D6-89FB-36EE478A43B8","bcr_patient_barcode":"TCGA-OR(...TRUNCATED) |
891b7a67-0a01-45f0-8a32-4a1b3e888f6c | TCGA-PK-A5HC | TCGA-ACC | https://portal.gdc.cancer.gov/cases/891b7a67-0a01-45f0-8a32-4a1b3e888f6c | Adrenal gland | Adenomas and Adenocarcinomas | Diagnosis | Informed Consent | -4 | null | null | {"demographic_id":"41caabd9-996c-58c3-a2d9-4f5aac2bd59a","submitter_id":"TCGA-PK-A5HC_demographic","(...TRUNCATED) | [{"diagnosis_id":"cbebacda-556b-5b47-b0e8-5621e3733dc4","submitter_id":"TCGA-PK-A5HC_diagnosis","adr(...TRUNCATED) | [{"follow_up_id":"86f23aea-ec0d-43bb-b767-bc7e97c1e6a2","submitter_id":"TCGA-PK-A5HC_follow_up5","ad(...TRUNCATED) | [] | [] | [{"sample_id":"18683430-ee50-4228-a1d0-0c9de0c0f25f","submitter_id":"TCGA-PK-A5HC-01A","biospecimen_(...TRUNCATED) | [{"tumor_sample_id":"18683430-ee50-4228-a1d0-0c9de0c0f25f","matched_normal_sample_id":"92d49bf6-f6ba(...TRUNCATED) | [] | {"os_event":0,"os_time":679.0,"dss_event":0,"dss_time":679.0,"pfi_event":1,"pfi_time":131.0,"dfi_eve(...TRUNCATED) | {"patient":{"bcr_patient_uuid":"891B7A67-0A01-45F0-8A32-4A1B3E888F6C","bcr_patient_barcode":"TCGA-PK(...TRUNCATED) |
a26b6f97-fd7e-4b96-bdf5-9df4f9233726 | TCGA-OR-A5L2 | TCGA-ACC | https://portal.gdc.cancer.gov/cases/a26b6f97-fd7e-4b96-bdf5-9df4f9233726 | Adrenal gland | Adenomas and Adenocarcinomas | Diagnosis | Consent Waiver | null | null | No | {"demographic_id":"9e0983e3-ddd4-5d41-a8fd-cf1db8a30c32","submitter_id":"TCGA-OR-A5L2_demographic","(...TRUNCATED) | [{"diagnosis_id":"b461588b-75a7-56ec-9ac2-f39bdff99cc0","submitter_id":"TCGA-OR-A5L2_diagnosis","adr(...TRUNCATED) | [{"follow_up_id":"5b660764-ddca-4c69-92eb-038493678d35","submitter_id":"TCGA-OR-A5L2_follow_up2","ad(...TRUNCATED) | [] | [] | [{"sample_id":"65d78b08-0b5c-415b-a4e3-41111eb42c09","submitter_id":"TCGA-OR-A5L2-01A","biospecimen_(...TRUNCATED) | [{"tumor_sample_id":"65d78b08-0b5c-415b-a4e3-41111eb42c09","matched_normal_sample_id":"b59782fb-1566(...TRUNCATED) | [] | {"os_event":1,"os_time":1852.0,"dss_event":0,"dss_time":1852.0,"pfi_event":0,"pfi_time":1852.0,"dfi_(...TRUNCATED) | {"patient":{"bcr_patient_uuid":"A26B6F97-FD7E-4B96-BDF5-9DF4F9233726","bcr_patient_barcode":"TCGA-OR(...TRUNCATED) |
0824b246-9fa2-4a8b-ad4c-1ffc7731bf7d | TCGA-P6-A5OG | TCGA-ACC | https://portal.gdc.cancer.gov/cases/0824b246-9fa2-4a8b-ad4c-1ffc7731bf7d | Adrenal gland | Adenomas and Adenocarcinomas | Diagnosis | Informed Consent | 0 | null | null | {"demographic_id":"a5957a98-4b3d-5651-a154-8adf70d31771","submitter_id":"TCGA-P6-A5OG_demographic","(...TRUNCATED) | [{"diagnosis_id":"4c402ccd-1dbe-4292-9b33-1d94742960de","submitter_id":"TCGA-P6-A5OG_diagnosis4","ad(...TRUNCATED) | [{"follow_up_id":"10d1fcd1-ec89-410a-aa2c-8df04aa7c866","submitter_id":"TCGA-P6-A5OG_follow_up6","ad(...TRUNCATED) | [] | [] | [{"sample_id":"328c543d-50a7-427f-a241-cb0c2fd7fd18","submitter_id":"TCGA-P6-A5OG-10A","biospecimen_(...TRUNCATED) | [{"tumor_sample_id":"af208939-bae3-4cb8-9ad3-f799c38fc1c0","matched_normal_sample_id":"328c543d-50a7(...TRUNCATED) | [{"sample_id":"af208939-bae3-4cb8-9ad3-f799c38fc1c0","aliquot_id":"b5a3bdce-d4ad-43a6-8fbc-1e9d31dc2(...TRUNCATED) | {"os_event":1,"os_time":383.0,"dss_event":1,"dss_time":383.0,"pfi_event":1,"pfi_time":11.0,"dfi_even(...TRUNCATED) | {"patient":{"bcr_patient_uuid":"0824B246-9FA2-4A8B-AD4C-1FFC7731BF7D","bcr_patient_barcode":"TCGA-P6(...TRUNCATED) |
92b67ca9-6c82-463e-9cc5-685a1d02ea3e | TCGA-P6-A5OH | TCGA-ACC | https://portal.gdc.cancer.gov/cases/92b67ca9-6c82-463e-9cc5-685a1d02ea3e | Adrenal gland | Adenomas and Adenocarcinomas | Diagnosis | Consent by Death | null | null | null | {"demographic_id":"9fb3f97f-3c1f-5de1-a061-b61419394a47","submitter_id":"TCGA-P6-A5OH_demographic","(...TRUNCATED) | [{"diagnosis_id":"5e0b9334-39ff-50c4-8e06-90abf6160c31","submitter_id":"TCGA-P6-A5OH_diagnosis","adr(...TRUNCATED) | [{"follow_up_id":"6844bd8f-6ecc-468a-99d1-366a47d2129f","submitter_id":"TCGA-P6-A5OH_follow_up","adv(...TRUNCATED) | [] | [] | [{"sample_id":"e9fc10af-598a-4b10-84b0-c77131daae5b","submitter_id":"TCGA-P6-A5OH-01A","biospecimen_(...TRUNCATED) | [{"tumor_sample_id":"e9fc10af-598a-4b10-84b0-c77131daae5b","matched_normal_sample_id":"f37b5a9a-ca76(...TRUNCATED) | [] | {"os_event":1,"os_time":0.0,"dss_event":1,"dss_time":0.0,"pfi_event":1,"pfi_time":0.0,"dfi_event":nu(...TRUNCATED) | {"patient":{"bcr_patient_uuid":"92B67CA9-6C82-463E-9CC5-685A1D02EA3E","bcr_patient_barcode":"TCGA-P6(...TRUNCATED) |
a3383252-1161-4b65-8bac-125a6eda3d08 | TCGA-OR-A5KQ | TCGA-ACC | https://portal.gdc.cancer.gov/cases/a3383252-1161-4b65-8bac-125a6eda3d08 | Adrenal gland | Adenomas and Adenocarcinomas | Diagnosis | Informed Consent | 25 | null | No | {"demographic_id":"9d787db9-12f8-5f84-89ae-01bb5e0322c5","submitter_id":"TCGA-OR-A5KQ_demographic","(...TRUNCATED) | [{"diagnosis_id":"8daf9a75-e5d7-5808-8b88-dd79a70fb356","submitter_id":"TCGA-OR-A5KQ_diagnosis","adr(...TRUNCATED) | [{"follow_up_id":"78bda601-5132-43ec-a4e0-99d1482ba1e5","submitter_id":"TCGA-OR-A5KQ_follow_up2","ad(...TRUNCATED) | [] | [] | [{"sample_id":"ee6f808d-bbd6-4e44-b17b-0f6673a6364f","submitter_id":"TCGA-OR-A5KQ-01A","biospecimen_(...TRUNCATED) | [{"tumor_sample_id":"ee6f808d-bbd6-4e44-b17b-0f6673a6364f","matched_normal_sample_id":"f48ee194-9f33(...TRUNCATED) | [] | {"os_event":0,"os_time":2677.0,"dss_event":0,"dss_time":2677.0,"pfi_event":0,"pfi_time":2677.0,"dfi_(...TRUNCATED) | {"patient":{"bcr_patient_uuid":"A3383252-1161-4B65-8BAC-125A6EDA3D08","bcr_patient_barcode":"TCGA-OR(...TRUNCATED) |
ec9c3efe-af61-4deb-b047-dcf7ee735fd2 | TCGA-OR-A5LI | TCGA-ACC | https://portal.gdc.cancer.gov/cases/ec9c3efe-af61-4deb-b047-dcf7ee735fd2 | Adrenal gland | Adenomas and Adenocarcinomas | Diagnosis | Consent Waiver | null | null | No | {"demographic_id":"14963079-c87c-54ea-9102-4256b1572bd1","submitter_id":"TCGA-OR-A5LI_demographic","(...TRUNCATED) | [{"diagnosis_id":"1577e70b-71cb-5432-bdb7-2fda4e118bf9","submitter_id":"TCGA-OR-A5LI_diagnosis","adr(...TRUNCATED) | [{"follow_up_id":"89807165-f9df-49aa-a687-f09afe46566d","submitter_id":"TCGA-OR-A5LI_follow_up6","ad(...TRUNCATED) | [] | [] | [{"sample_id":"d73c067c-18bc-4656-9d8b-133037272ef0","submitter_id":"TCGA-OR-A5LI-10A","biospecimen_(...TRUNCATED) | [{"tumor_sample_id":"e4bf6516-5305-4917-b278-f3c993884758","matched_normal_sample_id":"d73c067c-18bc(...TRUNCATED) | [] | {"os_event":1,"os_time":436.0,"dss_event":1,"dss_time":436.0,"pfi_event":1,"pfi_time":61.0,"dfi_even(...TRUNCATED) | {"patient":{"bcr_patient_uuid":"EC9C3EFE-AF61-4DEB-B047-DCF7EE735FD2","bcr_patient_barcode":"TCGA-OR(...TRUNCATED) |
11d8a9c2-14d8-4fc2-8388-386051e408b1 | TCGA-OR-A5KS | TCGA-ACC | https://portal.gdc.cancer.gov/cases/11d8a9c2-14d8-4fc2-8388-386051e408b1 | Adrenal gland | Adenomas and Adenocarcinomas | Diagnosis | Informed Consent | 107 | null | No | {"demographic_id":"cef0d254-66f0-526a-b7dc-760ff2d711e3","submitter_id":"TCGA-OR-A5KS_demographic","(...TRUNCATED) | [{"diagnosis_id":"14dd3c11-49a5-5f4d-8ed6-dd2a46b02f70","submitter_id":"TCGA-OR-A5KS_diagnosis","adr(...TRUNCATED) | [{"follow_up_id":"1909d779-383c-452f-bf72-907a9c845a91","submitter_id":"TCGA-OR-A5KS_follow_up","adv(...TRUNCATED) | [] | [] | [{"sample_id":"67924e9c-059b-4c9c-861e-4c33e9bf5d57","submitter_id":"TCGA-OR-A5KS-01A","biospecimen_(...TRUNCATED) | [{"tumor_sample_id":"67924e9c-059b-4c9c-861e-4c33e9bf5d57","matched_normal_sample_id":"7e3f5840-5f91(...TRUNCATED) | [] | {"os_event":0,"os_time":2549.0,"dss_event":0,"dss_time":2549.0,"pfi_event":0,"pfi_time":2549.0,"dfi_(...TRUNCATED) | {"patient":{"bcr_patient_uuid":"11D8A9C2-14D8-4FC2-8388-386051E408B1","bcr_patient_barcode":"TCGA-OR(...TRUNCATED) |
TCGA Patients (Open Access)
Open-access TCGA data from the NCI Genomic Data Commons (GDC). Covers all 33 TCGA projects.
This view presents one HuggingFace subset per TCGA project, with one row per patient. See the tcga-tabular-open companion for a per-table view of the same underlying data.
- Generated: 2026-05-09 22:03:39 UTC
- Schema: derived from the GDC Data Dictionary.
- GDC data release: Data Release 45.0 - December 04, 2025
Data model
Where the data comes from
Three sources feed each project's data, all open-access:
Case-level clinical structure — fetched from the GDC
/casesendpoint, returning the full nested case JSON (demographic + diagnoses → treatments + follow_ups + exposures + family_histories + samples → portions → analytes → aliquots). The biospecimen subtree on each case:case one patient (TCGA-XX-1234) └── sample physical specimen taken from the patient at one timepoint (Primary Tumor, Solid Tissue Normal, Blood Derived Normal, ...) └── portion a piece of that sample for a specific lab process └── analyte extracted material of one type (DNA or RNA) └── aliquot a vial of that analyte handed off for sequencingPer-modality molecular files — discovered via
/files(filtered by the clauses in the table below) and downloaded via/data. Each combination locks onedata_typeto a specific GDC pipeline so a future GDC addition can't quietly substitute a different pipeline under the samedata_type.BCR Clinical Supplement biotabs — original Biospecimen Core Resource (BCR) clinical forms shipped as per-project TSVs (one per form: patient, follow_up, nte, drug, radiation, etc.). The harmonized
/casesendpoint drops or under-populates a number of clinical fields the BCR-original biotabs preserve. The schema varies by cancer type (e.g. BLCA's BCG-response columns don't exist in CHOL's hepatic-marker forms), so each project's biotabs ship only the columns they actually carry. Discovered the same way (/filesthen/data) — see the filter table below.
Source data filters (canonical)
Same in both views of the dataset; each row locks the /files query
for one source:
| data_type | data_format | data_category | experimental_strategy | analysis.workflow_type |
|---|---|---|---|---|
Masked Somatic Mutation |
MAF |
Simple Nucleotide Variation |
WXS |
Aliquot Ensemble Somatic Variant Merging and Masking |
Gene Expression Quantification |
TSV |
Transcriptome Profiling |
RNA-Seq |
STAR - Counts |
Clinical Supplement |
bcr biotab |
Clinical |
How each source appears in this view
| Source | Where it lands |
|---|---|
GDC /cases |
nested fields on each patient row (demographic, diagnoses, follow_ups, exposures, family_histories, samples); gdc_portal_url link added |
| Masked Somatic Mutation MAFs | samples_masked_somatic_mutation array on each patient row (sample FKs resolved alongside GDC's aliquot UUIDs) |
| Gene Expression Quantification | samples_gene_expression_quantification array on each patient row (stranded_first / stranded_second dropped — GDC harmonizes as unstranded) |
| BCR Clinical Supplements | clinical_supplement struct on each patient row, with sub-fields patient (1 dict) and follow_ups / ntes / drugs / radiations / ablations / omfs (lists of dicts). Sub-fields with no data for the project are omitted. |
Specific to this view
- Convenience: each row carries
samples_<modality>array columns so you can column-project just the molecular data you need without walking the nested GDC entities. - Loading: the
tcga2hfpackage ships a typedTcgaHfPatientpydantic model that mirrors this schema and adds convenience joins (tumor/normal pairs, mutations-by-gene, expression-by-gene, longitudinal timeline).
Provenance pinned per build
GET /status→data_release/tag/commitsaved in each project'sgdc_status.json.GET /v0/submission/_dictionary/_all→ schema dictionary snapshot saved alongside the raw data; its SHA-256 is recorded ingdc_status.json.
See the repository for full request payloads, filter clauses, and the build pipeline source.
Survival endpoints (survival_derived)
We have provided a supplement to the GDC source data: re-derived survival endpoints — Overall Survival (OS), Disease-Specific Survival (DSS), Progression-Free Interval (PFI), Disease-Free Interval (DFI) — following the algorithm published by Liu et al. 2018 (DOI 10.1016/j.cell.2018.02.052).
Each patient row carries a top-level survival_derived struct with eight sub-fields: os_event / os_time, dss_event / dss_time, pfi_event / pfi_time, dfi_event / dfi_time. *_event is 0/1 (event observed vs censored); *_time is
days from index_date (TCGA: diagnosis date). DFI is null for SKCM /
THYM / UVM / LAML — Liu specifies no DFI for those tumor types.
We've reimplemented Liu's method against the current TCGA data and find broad agreement with the original curated CDR. Differences exist and are expected: this is a newer release of the underlying GDC data, so re-curated clinical values, post-2018 patient additions, and schema migrations all contribute to the gap. This work is evolving; see the repository for the full reproduction report and per-endpoint methodology.
Why we don't ship Liu's curated 2018 values directly: the CDR is a frozen 2018 snapshot derived from a since-modified GDC release. Including those values would lock in irreproducible source-data drift. We re-derive on every build, so the values reflect the current GDC and are reproducible from this dataset's other tables alone.
Loading
from datasets import load_dataset
# One config per TCGA project.
luad = load_dataset("gabrielaltay/tcga-patients-open", "TCGA-LUAD")
Each row is one patient with the full GDC case structure nested
in-place plus the survival_derived struct.
GDC references
- Data dictionary (every entity + field definition)
- Biospecimen Encyclopedia
- MAF format spec
- Gene Expression Quantification spec
- Sample Type codes
- TCGA Barcode reference
License & redistribution
Per the NCI GDC Data Analysis Policy:
The GDC itself places no restrictions (other than attempts at reidentification) on analysis or publication of open access data provided through the GDC Data Portal.
Per the NCI TCGA citation page:
Moratoria on all cancer types are now lifted and all TCGA data are available without restrictions on their use in publications or presentations.
Per the GDC Data Access Processes and Tools page:
Open access data generally includes high level genomic data that is not individually identifiable, as well as most clinical and all biospecimen data elements.
Restrictions on use
Users of any data provided by GDC, whether open or controlled access, agree not to attempt to reidentify any individual participant in any study represented by GDC data, for any purpose whatever. (source)
Required acknowledgement
If you publish or present results derived from this dataset, include the NCI-required TCGA acknowledgement:
The results here are in whole or part based upon data generated by the TCGA Research Network: https://www.cancer.gov/tcga.
Suggested citations:
- Grossman, R. L., et al. (2016). Toward a Shared Vision for Cancer Genomic Data. NEJM, 375(12), 1109-1112.
- The Cancer Genome Atlas Research Network. https://www.cancer.gov/tcga
- NCI Genomic Data Commons. https://gdc.cancer.gov
Policy references: GDC Policies, GDC Encyclopedia — Controlled Access (defines what is not in this dataset), NIH Genomic Data Sharing Policy.
Disclaimer
This project is not affiliated with the NCI, GDC, or the TCGA Research
Network. It is an experimental open-source pipeline that may change
significantly between versions. Pipeline source: galtay/tcga2hf.
- Downloads last month
- 96